{"database": "lobbying", "table": "lobbying_activities", "rows": [[3046315, "69f53209-c95c-4389-a023-70fa186e7b3b", "Q3", "RED+BLUE STRATEGIES", 400693064, "QUEST DIAGNOSTICS INCORPORATED", 2023, "third_quarter", "MMM", "Issues related to specific, federally-reimbursed drug testing protocols. H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program. Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2023-10-09T12:44:06-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3046315"], "units": {}, "query_ms": 0.30769407749176025, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}